A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells

References

• Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG. p57KIP2: “Kip”ing the cell under control. Mol Cancer Res 2009; 7:1902-19; PMID:19934273; http://dx.doi.org/10.1158/1541-7786.MCR-09-0317
   PubMed Web of Science ®Google Scholar
• Yan Y, Frisen J, Lee MH, Massague J, Barbacid M. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 1997; 11:973-83; PMID:9136926; http://dx.doi.org/10.1101/gad.11.8.973
   PubMed Web of Science ®Google Scholar
• Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA, Elledge SJ. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997; 387:151-8; PMID:9144284; http://dx.doi.org/10.1038/387151a0
   PubMed Web of Science ®Google Scholar
• Eggermann T, Binder G, Brioude F, Maher ER, Lapunzina P, Cubellis MV, Bergada I, Prawitt D, Begemann M. CDKN1C mutations: two sides of the same coin. Trends Mol Med 2014; 20:614-22; PMID:25262539; http://dx.doi.org/10.1016/j.molmed.2014.09.001
   PubMed Web of Science ®Google Scholar
• Lee MH, Reynisdottir I, Massague J. Cloning or P57(Kip2), a Cyclin-Dependent Kinase Inhibitor with Unique Domain-Structure and Tissue Distribution. Genes Dev 1995; 9:639-49; PMID:7729683; http://dx.doi.org/10.1101/gad.9.6.639
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Edwards MC, Bai C, Parker S, Zhang PM, Baldini A, Harper JW, Elledge SJ. P57(Kip2), a Structurally Distinct Member of the P21(Cip1) Cdk Inhibitor Family, Is a Candidate Tumor-Suppressor Gene. Genes Dev 1995; 9:650-62; PMID:7729684; http://dx.doi.org/10.1101/gad.9.6.650
   PubMed Web of Science ®Google Scholar
• Susaki E, Nakayama K, Yamasaki L, Nakayama KI. Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model. Proc Nat Acad Sci U S A 2009; 106:5192-7; PMID:19276117; http://dx.doi.org/10.1073/pnas.0811712106
   PubMed Web of Science ®Google Scholar
• Nagahama H, Hatakeyama S, Nakayama K, Nagata M, Tomita K, Nakayama K. Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27(Kip1) and p57(Kip2) during mouse development. Anat Embryol 2001; 203:77-87; PMID:11218061; http://dx.doi.org/10.1007/s004290000146
   PubMedGoogle Scholar
• Hatada I, Mukai T. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 1995; 11:204-6; PMID:7550351; http://dx.doi.org/10.1038/ng1095-204
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Thompson JS, Edwards MC, Bartletta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ, Feinberg AP. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Nat Acad Sci U S A 1996; 93:3026-30; PMID:8610162; http://dx.doi.org/10.1073/pnas.93.7.3026
   PubMed Web of Science ®Google Scholar
• Fitzpatrick GV, Soloway PD, Higgins MJ. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat Genet 2002; 32:426-31; PMID:12410230; http://dx.doi.org/10.1038/ng988
   PubMed Web of Science ®Google Scholar
• Lewis A, Mitsuya K, Umlauf D, Smith P, Dean W, Walter J, Higgins M, Feil R, Reik W. Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation. Nat Genet 2004; 36:1291-5; PMID:15516931; http://dx.doi.org/10.1038/ng1468
   PubMed Web of Science ®Google Scholar
• Smilinich NJ, Day CD, Fitzpatrick GV, Caldwell GM, Lossie AC, Cooper PR, Smallwood AC, Joyce JA, Schofield PN, Reik W, et al. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc Nat Acad Sci U S A 1999; 96:8064-9; PMID:10393948; http://dx.doi.org/10.1073/pnas.96.14.8064
   PubMed Web of Science ®Google Scholar
• Umlauf D, Goto Y, Cao R, Cerqueira F, Wagschal A, Zhang Y, Feil R. Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet 2004; 36:1296-300; PMID:15516932; http://dx.doi.org/10.1038/ng1467
   PubMed Web of Science ®Google Scholar
• Fitzpatrick GV, Pugacheva EM, Shin JY, Abdullaev Z, Yang Y, Khatod K, Lobanenkov VV, Higgins MJ. Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1. Mol Cell Biol 2007; 27:2636-47; PMID:17242189; http://dx.doi.org/10.1128/MCB.02036-06
   PubMed Web of Science ®Google Scholar
• Mancini-DiNardo D, Steele SJS, Ingram RS, Tilghman SM. A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer. Hum Mol Genet 2003; 12:283-94; PMID:12554682; http://dx.doi.org/10.1093/hmg/ddg024
   PubMed Web of Science ®Google Scholar
• Kanduri C. Kcnq1ot1: A chromatin regulatory RNA. Semin Cell Dev Biol 2011; 22:343-50; PMID:21345374; http://dx.doi.org/10.1016/j.semcdb.2011.02.020
   PubMed Web of Science ®Google Scholar
• Demars J, Gicquel C. Epigenetic and genetic disturbance of the imprinted 11p15 region in Beckwith-Wiedemann and Silver-Russell syndromes. Clin Genet 2012; 81:350-61; PMID:22150955; http://dx.doi.org/10.1111/j.1399-0004.2011.01822.x
   PubMed Web of Science ®Google Scholar
• Figliola R, Maione R. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors. J Cell Physiol 2004; 200:468-75; PMID:15254975; http://dx.doi.org/10.1002/jcp.20044
   PubMed Web of Science ®Google Scholar
• Berkes CA, Tapscott SJ. MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 2005; 16:585-95; PMID:16099183; http://dx.doi.org/10.1016/j.semcdb.2005.07.006
   PubMed Web of Science ®Google Scholar
• Figliola R, Busanello A, Vaccarello G, Maione R. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation. J Mol Biol 2008; 380:265-77; PMID:18513743; http://dx.doi.org/10.1016/j.jmb.2008.05.004
   PubMed Web of Science ®Google Scholar
• Vaccarello G, Figliola R, Cramerotti S, Novelli F, Maione R. p57Kip2 is induced by MyoD through a p73-dependent pathway. J Mol Biol 2006; 356:578-88; PMID:16405903; http://dx.doi.org/10.1016/j.jmb.2005.12.024
   PubMed Web of Science ®Google Scholar
• Battistelli C, Busanello A, Maione R. Functional interplay between MyoD and CTCF in regulating long-range chromatin interactions during differentiation. J Cell Sci 2014; 127:3757-67; PMID:25002401; http://dx.doi.org/10.1242/jcs.149427
   PubMed Web of Science ®Google Scholar
• Busanello A, Battistelli C, Carbone M, Mostocotto C, Maione R. MyoD regulates p57(kip2) expression by interacting with a distant cis-element and modifying a higher order chromatin structure. Nucleic Acids Res 2012; 40:8266-75; PMID:22740650; http://dx.doi.org/10.1093/nar/gks619
   PubMed Web of Science ®Google Scholar
• Balint E, Phillips AC, Kozlov S, Stewart CL, Vousden KH. Induction of p57(KIP2) expression by p73 beta. Proc Nat Acad Sci U S A 2002; 99:3529-34; PMID:11891335; http://dx.doi.org/10.1073/pnas.0624-91899
   PubMed Web of Science ®Google Scholar
• Rothschild G, Zhao X, Iavarone A, Lasorella A. E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells. Mol Cell Biol 2006; 26:4351-61; PMID:16705184; http://dx.doi.org/10.1128/MCB.01743-05
   PubMed Web of Science ®Google Scholar
• Bergstrom DA, Penn BH, Strand A, Perry RL, Rudnicki MA, Tapscott SJ. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell 2002; 9:587-600; PMID:11931766; http://dx.doi.org/10.1016/S1097-2765(02)00481-1
   PubMed Web of Science ®Google Scholar
• Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan MT, Ruzzo WL, et al. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 2010; 18:662-74; PMID:20412780; http://dx.doi.org/10.1016/j.devcel.2010.02.014
   PubMed Web of Science ®Google Scholar
• Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011; 25:1010-22; PMID:21576262; http://dx.doi.org/10.1101/gad.2037511
   PubMed Web of Science ®Google Scholar
• Espada J, Esteller M. DNA methylation and the functional organization of the nuclear compartment. Semin Cell Dev Biol 2010; 21:238-46; PMID:19892028; http://dx.doi.org/10.1016/j.semcdb.2009.10.006
   PubMed Web of Science ®Google Scholar
• Schubeler D. Function and information content of DNA methylation. Nature 2015; 517:321-6; PMID:25592537; http://dx.doi.org/10.1038/nature14192
   PubMed Web of Science ®Google Scholar
• Miranda TB, Jones PA. DNA methylation: The nuts and bolts of repression. J Cell Physiol 2007; 213:384-90; PMID:17708532; http://dx.doi.org/10.1002/jcp.21224
   PubMed Web of Science ®Google Scholar
• Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295-304; PMID:19308066; http://dx.doi.org/10.1038/nrg2540
   PubMed Web of Science ®Google Scholar
• Clouaire T, Stancheva I. Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci 2008; 65:1509-22; PMID:18322651; http://dx.doi.org/10.1007/s00018-008-7324-y
   PubMed Web of Science ®Google Scholar
• Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 1993; 3:226-31; PMID:8504247; http://dx.doi.org/10.1016/0959-437X(93)90027-M
   PubMed Web of Science ®Google Scholar
• Bhogal B, Arnaudo A, Dymkowski A, Best A, Davis TL. Methylation at mouse Cdkn1c is acquired during postimplantation development and functions to maintain imprinted expression. Genomics 2004; 84:961-70; PMID:15533713; http://dx.doi.org/10.1016/j.ygeno.2004.08.004
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T, et al. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Oncogene 2002; 21:2741-9; PMID:11965547; http://dx.doi.org/10.1038/sj.onc.1205376
   PubMed Web of Science ®Google Scholar
• Kuang SQ, Ling X, Sanchez-Gonzalez B, Yang H, Andreeff M, Garcia-Manero G. Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation. Oncogene 2007; 26:1439-48; PMID:16936778; http://dx.doi.org/10.1038/sj.onc.1209907
   PubMed Web of Science ®Google Scholar
• Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E, Mori N, Saito H, Kinoshita T. Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood 2002; 100:2572-7; PMID:12239171; http://dx.doi.org/10.1182/blood-2001-11-0026
   PubMed Web of Science ®Google Scholar
• Shin JY, Kim HS, Park J, Park JB, Lee JY. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res 2000; 60:262-5; PMID:10667572
   PubMed Web of Science ®Google Scholar
• Fuso A, Ferraguti G, Grandoni F, Ruggeri R, Scarpa S, Strom R, Lucarelli M. Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5′-flanking region: a priming effect on the spreading of active demethylation. Cell Cycle 2010; 9:3965-76; PMID:20935518; http://dx.doi.org/10.4161/cc.9.19.13193
   PubMed Web of Science ®Google Scholar
• Konieczny SF, Emerson CP, Jr. 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination. Cell 1984; 38:791-800; PMID:6207933; http://dx.doi.org/10.1016/0092-8674(84)90274-5
   PubMed Web of Science ®Google Scholar
• Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979; 17:771-9; PMID:90553; http://dx.doi.org/10.1016/0092-8674(79)90317-9
   PubMed Web of Science ®Google Scholar
• Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51:987-1000; PMID:3690668; http://dx.doi.org/10.1016/0092-8674(87)90585-X
   PubMed Web of Science ®Google Scholar
• Lassar AB, Paterson BM, Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 1986; 47:649-56; PMID:2430720; http://dx.doi.org/10.1016/0092-8674(86)90507-6
   PubMed Web of Science ®Google Scholar
• El Kharroubi A, Piras G, Stewart CL. DNA demethylation reactivates a subset of imprinted genes in uniparental mouse embryonic fibroblasts. J Biol Chem 2001; 276:8674-80; PMID:11124954; http://dx.doi.org/10.1074/jbc.M009392200
   PubMed Web of Science ®Google Scholar
• Chandra S, Baribault C, Lacey M, Ehrlich M. Myogenic differential methylation: diverse associations with chromatin structure. Biology 2014; 3:426-51; PMID:24949935; http://dx.doi.org/10.3390/biology30-20426
   PubMedGoogle Scholar
• Tsumagari K, Baribault C, Terragni J, Varley KE, Gertz J, Pradhan S, Badoo M, Crain CM, Song L, Crawford GE, et al. Early de novo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics 2013; 8:317-32; PMID:23417056; http://dx.doi.org/10.4161/epi.23989
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Vertino PM, Cheng X. Molecular coupling of DNA methylation and histone methylation. Epigenomics 2010; 2:657-69; PMID:21339843; http://dx.doi.org/10.2217/epi.10.44
   PubMed Web of Science ®Google Scholar
• Torres IO, Fujimori DG. Functional coupling between writers, erasers and readers of histone and DNA methylation. Curr Opin Struct Biol 2015; 35:68-75; PMID:26496625; http://dx.doi.org/10.1016/j.sbi.2015.09.007
   PubMed Web of Science ®Google Scholar
• Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 2003; 12:1591-8; PMID:14690610; http://dx.doi.org/10.1016/S1097-2765(03)00479-9
   PubMed Web of Science ®Google Scholar
• Rao VK, Ow JR, Shankar SR, Bharathy N, Manikandan J, Wang Y, Taneja R. G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation. Nucleic Acids Res 2016.
   Web of Science ®Google Scholar
• Cheng X. Structural and functional coordination of DNA and histone methylation. Cold Spring Harb Perspect Biol 2014; 6; PMID:25085914; http://dx.doi.org/10.1101/cshperspect.a018747
   PubMed Web of Science ®Google Scholar
• Egger G, Aparicio AM, Escobar SG, Jones PA. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2′-deoxycytidine treatment. Cancer Res 2007; 67:346-53; PMID:17210717; http://dx.doi.org/10.1158/0008-5472.CAN-06-2845
   PubMed Web of Science ®Google Scholar
• McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin SB. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 2006; 66:3541-9; PMID:16585178; http://dx.doi.org/10.1158/0008-5472.CAN-05-2481
   PubMed Web of Science ®Google Scholar
• Yang X, Karuturi RK, Sun F, Aau M, Yu K, Shao R, Miller LD, Tan PB, Yu Q. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. Plos One 2009; 4:e5011; PMID:19340297; http://dx.doi.org/10.1371/journal.pone.0005011
   PubMed Web of Science ®Google Scholar
• Mozzetta C, Boyarchuk E, Pontis J, Ait-Si-Ali S. Sound of silence: the properties and functions of repressive Lys methyltransferases. Nat Rev Mol Cell Biol 2015; 16:499-513; PMID:26204160; http://dx.doi.org/10.1038/nrm4029
   PubMed Web of Science ®Google Scholar
• Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 2009; 41:246-50; PMID:19151716; http://dx.doi.org/10.1038/ng.297
   PubMed Web of Science ®Google Scholar
• Ling BM, Gopinadhan S, Kok WK, Shankar SR, Gopal P, Bharathy N, Wang Y, Taneja R. G9a mediates Sharp-1-dependent inhibition of skeletal muscle differentiation. Mol Biol Cell 2012; 23:4778-85; PMID:23087213; http://dx.doi.org/10.1091/mbc.E12-04-0311
   PubMed Web of Science ®Google Scholar
• Mal A, Harter ML. MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc Nat Acad Sci U S A 2003; 100:1735-9; PMID:12578986; http://dx.doi.org/10.1073/pnas.0437843100
   PubMed Web of Science ®Google Scholar
• Ling BM, Bharathy N, Chung TK, Kok WK, Li S, Tan YH, Rao VK, Gopinadhan S, Sartorelli V, Walsh MJ, et al. Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc Nat Acad Sci U S A 2012; 109:841-6; PMID:22215600; http://dx.doi.org/10.1073/pnas.1111628109
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, Jones PA. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 2002; 62:6456-61; PMID:12438235
   PubMed Web of Science ®Google Scholar
• Wozniak RJ, Klimecki WT, Lau SS, Feinstein Y, Futscher BW. 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene 2007; 26:77-90; PMID:16799634; http://dx.doi.org/10.1038/sj.onc.1209763
   PubMed Web of Science ®Google Scholar
• Kury P, Greiner-Petter R, Cornely C, Jurgens T, Muller HW. Mammalian achaete scute homolog 2 is expressed in the adult sciatic nerve and regulates the expression of Krox24, Mob-1, CXCR4, and p57kip2 in Schwann cells. J Neurosci 2002; 22:7586-95; PMID:12196582
   PubMed Web of Science ®Google Scholar